Site selective syntheses of [(3)H]omeprazole using hydrogen isotope exchange chemistry.

doi:10.1002/jlcr.3346

Paper

Site selective syntheses of [(3)H]omeprazole using hydrogen isotope exchange chemistry.

Published Sep 10, 2015 · D. Schenk, Scott R Pollack

Journal of labelled compounds & radiopharmaceuticals

6

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Omeprazole (Prilosec®) is a selective and irreversible proton pump inhibitor used to treat various medical conditions related to the production of excess stomach acids. It functions by suppressing secretion of those acids. Radiolabeled compounds are commonly employed in the drug discovery and development process to support efforts including library screening, target identification, receptor binding, assay development and validation and safety assessment. Herein, we describe synthetic approaches to the controlled and selective labeling of omeprazole with tritium via hydrogen isotope exchange chemistry. The chemistry may also be used to prepare tritium labeled esomeprazole (Nexium®), the active pure (S)-enantiomer of omeprazole.

Study Snapshot

This study demonstrates a controlled and selective labeling of omeprazole with tritium using hydrogen isotope exchange chemistry, potentially benefiting drug discovery and development efforts.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Site selective syntheses of [(3)H]omeprazole using hydrogen isotope exchange chemistry.

References

Citations